NON-ANIMAL NAVIGATOR
LIVE

Serial Number

99270216

Owner

Certara USA, Inc.

Attorney

Carrie Webb Olson

First Use Date

Apr 14, 2025

Filing Date

Jul 7, 2025

Add to watchlist:

No watchlists yet
View on USPTO

NON-ANIMAL NAVIGATOR Trademark

Serial Number: 99270216 • Registration: 8201865

NON-ANIMAL NAVIGATOR is a trademark filed by Certara USA, Inc. on July 7, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Certara USA, Inc. (25 trademarks)

222 S. Central Ave., Ste 2008

Entity Type: 99

Trademark Details

Filing Date

July 7, 2025

Registration Date

April 7, 2026

First Use Anywhere

April 14, 2025

First Use in Commerce

April 14, 2025

Published for Opposition

February 17, 2026

Goods & Services

Downloadable computer software to assist with product development, data analysis, and management in the field of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for transmitting, analyzing and generating reports; Downloadable computer software for data processing and analysis in the fields of pharmaceuticals, pharmacometrics and drug research; Downloadable computer software for research with dashboard functionality providing grid and graphical visualizations of formatted data allowing users to analyze and visually identify relationships among histopathology, clinical chemistry, and hematology findings in the field of pharmaceutical development; Downloadable computer software in the field of pharmaceutical development facilitating simultaneous analysis of formatted data from multiple studies, data querying, mining and visualization for pharmaceutical research and development using formatted data files as data sources; Downdoadable computer software for drug development research; Downloadable software for use in modeling, simulating, and predicting pharmacokinetic and toxicological outcomes to support drug development and regulatory submissions; Downloadable computer software for use in evaluating preclinical safety using in vitro, in silico, and biosimulation methodologies.

Scientific research, namely, chemical, biochemical, and molecular analysis, research and testing services in the pharmaceutical, pharmacometrics, drug research, biotechnology and agrochemical industries, and the development and testing of new pharmaceutical products for others; Design of customized cheminformatics software for others; Consultation in the field of computer software and computer hardware design for others; Technological consultation in the field of computer networking; Software as a service (SAAS) services featuring software for data integration; Software as a service (SAAS) services featuring software for creating a network of disparate data; Software as a service (SAAS) services featuring software using artificial intelligence for data integration; Providing online non-downloadable software for data integration; Providing online non-downloadable software for creating networks of disparate data; Providing online non-downloadable software using artificial intelligence for data integration; Providing temporary use of non-downloadable computer software for integrating various databases in the fields of pharmaceuticals, pharmacometrics, drug research and logical data modeling; Providing temporary use of non-downloadable software for the collection, tracking, editing, organizing, analyzing, transmission, storage and sharing of data and information; Platform as a service (PAAS) featuring computer software platforms for predictive data analytics, data modeling and analytics; Providing online non-downloadable software for data input, integration and analytics in the fields of pharmaceuticals, pharmacometrics and drug research; Consultancy in the fields of information technology, pharmacology and software design; Software as a service (SAAS) featuring software for modeling, simulating, and analyzing biological and pharmacological data to support drug development; Providing temporary use of non-downloadable software for predicting preclinical safety outcomes using biosimulation and artificial intelligence; Consulting services in the field of scientific and technological research related to testing alternatives for pharmaceuticals; Consulting services in the field of pharmaceutical drug development, namely, advising on testing methods, toxicological data interpretation, and regulatory strategy related to preclinical safety assessment

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 7, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 7, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 14, 2026 XAEC
ASSIGNED TO LIE
Jan 13, 2026 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 13, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 13, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 13, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 9, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 9, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 25, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 25, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 25, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 24, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 7, 2025 MAFR
NEW APPLICATION ENTERED
Jul 7, 2025 NWAP